Important resolutions of 2022 Annual General
shareholders' meeting
Date of events
2022/06/15
To which item it meets
paragraph 18
Statement
1.Date of the shareholders' meeting:2022/06/15
2.Important resolutions I.Profit distribution/deficit compensation:
Approved the proposal for distribution of 2021 profits.
3.Important resolutions II.Amendments of the company charter:
Approved the amendments to the company charter.
4.Important resolutions III.Business report and financial statements:
Approved the Business Report and Financial Statements of 2021
5.Important resolutions IV.Election for directors and supervisors:None.
6.Important resolutions V.Other matters:
(1)Approve the amendments of "Regulations Governing the Acquisition and
Disposal of Assets".
(2)Approve the amendments of "Rules of procedure for shareholder's meeting".
7.Any other matters that need to be specified:None.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Sofiva Genomics Co. Ltd. published this content on 15 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 June 2022 06:32:10 UTC.
Sofiva Genomics Co Ltd is a Taiwan-based company mainly engaged in provision of deoxyribonucleic acid (DNA) testing services. The Company's DNA testing services mainly contain reproductive medicine testing, pregnant women testing, newborn testing, rare disease genetic testing, personalized genetic testing, cancer genetic testing, and genetic counseling services. Reproductive Medicine testing is pre-implantation genetic diagnosis for embryos. Pregnant women testing services predict the occurrence of preeclampsia and provide prenatal diagnosis. Neonatal testing services provide neonatal hearing loss genetic test, respiratory distress syndrome test, congenital cytomegalovirus infection test service. Personalized genetic testing services includes human papilloma virus screening, paternity testing, telomere testing, chronic disease and cardiovascular disease and other genetic research. Cancer genetic testing services is applied to cancer patients.
SOFIVA GENOMICS CO.,LTD. 
